Gabriele Lignani
Affiliations: | UCL Institute of Neurology, London, England, United Kingdom |
Area:
NeuroscienceGoogle:
"Gabriele Lignani"Mean distance: (not calculated yet)
Parents
Sign in to add mentorFabio Benfenati | grad student | 2009-2014 | |
Schorge Stephanie | post-doc | 2014-2016 | |
Dimitri Kullmann | post-doc | 2016-2018 |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Almacellas Barbanoj A, Graham RT, Maffei B, et al. (2023) Anti-seizure gene therapy for focal cortical dysplasia. Brain : a Journal of Neurology |
Moschetta M, Ravasenga T, De Fusco A, et al. (2022) Ca binding to synapsin I regulates resting Ca and recovery from synaptic depression in nerve terminals. Cellular and Molecular Life Sciences : Cmls. 79: 600 |
Qiu Y, O'Neill N, Maffei B, et al. (2022) On-demand cell-autonomous gene therapy for brain circuit disorders. Science (New York, N.Y.). 378: 523-532 |
Prestigio C, Ferrante D, Marte A, et al. (2021) REST/NRSF drives homeostatic plasticity of inhibitory synapses in a target-dependent fashion. Elife. 10 |
Turner TJ, Zourray C, Schorge S, et al. (2020) Recent advances in gene therapy for neurodevelopmental disorders with epilepsy. Journal of Neurochemistry |
Lignani G, Baldelli P, Marra V. (2020) Homeostatic Plasticity in Epilepsy. Frontiers in Cellular Neuroscience. 14: 197 |
Colasante G, Qiu Y, Massimino L, et al. (2020) In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy. Brain : a Journal of Neurology |
Colasante G, Lignani G, Brusco S, et al. (2019) dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Lugarà E, De Fusco A, Lignani G, et al. (2019) Synapsin I Controls Synaptic Maturation of Long-Range Projections in the Lateral Amygdala in a Targeted Selective Fashion. Frontiers in Cellular Neuroscience. 13: 220 |
Weston M, Kaserer T, Wu A, et al. (2019) Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics. Science Advances. 5: eaaw1567 |